Machine learning predicts side effects from chemotherapy

In collaboration with Rigshospitalet, researchers from DTU Health Technology have developed a machine learning model that can predict chemotherapy-associated nephrotoxicity, a particularly significant side effect in patients treated with cisplatin.

Photo
The scientists at DTU Health Tech use AI to combine clinical files and genetics for predicting patient outcome
Source: Technical University of Denmark

Testicular cancer is the most common cancer in young men. The number of new cases is increasing worldwide. There is a relatively high survival rate, with 95% surviving after 10 years - if detected in time and treated properly. However, the standard chemotherapy includes cisplatin, which has a wide range of long-term side effects, one of which can be nephrotoxicity.

“In testicular cancer patients, cisplatin-based chemotherapy is essential to ensure a high cure rate. Unfortunately, treatment can cause side effects, including renal impairment. However, we are not able to pinpoint who ends up having side effects and who does not,” says Jakob Lauritsen from Rigshospitalet.

Patient data is key to knowledge

The researchers therefore asked the question: How far can we go in predicting nephrotoxicity risk in these patients using machine learning? First, it required some patient data. "Using a cohort of testicular-cancer patients from Denmark– in collaboration with Rigshospitalet, we developed a machine learning predictive model to tackle this problem" says Sara Garcia, a researcher at DTU Health Technology, who, together with Jakob Lauritsen, are the first authors of an article published recently in JNCI Cancer Spectrum.

The high-quality of Danish patient records allowed the identification of key patients, and a technology partnership between DMAC and YouDoBio facilitated DNA collection from patients at their homes using postal delivered saliva kits. The project, originally funded by the Danish Cancer Society, saw the development of several analyses strategies of genomics and patient data, bringing forward the promise of artificial intelligence for integration of diverse data streams.

Best predictions for low-risk patients

A risk score for an individual to develop nephrotoxicity during chemotherapy was generated, and key genes likely at play were proposed. Patients were classified into high, low, and intermediate risk. For the high-risk, the model was able to correctly predict 67% of affected patients, while for the low-risk, the model correctly predicted 92% of the patients that did not develop nephrotoxicity.

“Understanding how and where AI technologies can be applied in clinical care, is increasingly important also in the future of responsible AI. Despite patient data complexity, the high quality of Danish registries and clinical research make it a great environment for exploring new data methodologies” says Ramneek Gupta. “Being able to predict late side-effects will ultimately give us the opportunity for preventive action and improved quality of life” adds Gedske Daugaard, who is joint senior author with Ramneek Gupta.

Subscribe to our newsletter

Related articles

AI predicts effectiveness of immunotherapy

AI predicts effectiveness of immunotherapy

Scientists can determine which lung-cancer patients will benefit from expensive immunotherapy.

App monitors cancer patients' quality of life

App monitors cancer patients' quality of life

A team from the Universitat Politècnica de València (UPV) has developed a new mobile application that facilitates the continuous monitoring of the quality of life of cancer patients.

Machine learning helps diagnose leukemia

Machine learning helps diagnose leukemia

Researchers at the University of Bonn show how artificial intelligence improves the evaluation of blood analysis data.

A pen to pin down the fringes of cancer

A pen to pin down the fringes of cancer

The MasSpec Pen has shown to accurately differentiate healthy and cancerous tissue from banked pancreas samples during surgery.

Machine learning fuels personalised cancer medicine

Machine learning fuels personalised cancer medicine

A tool, based on machine learning methods, that evaluates the potential contribution of all possible mutations in a gene in a given type of tumour to the development and progression of cancer.

Immunotherapy response studied in body-on-a-chip models

Immunotherapy response studied in body-on-a-chip models

Clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer.

Quantum physics helps destroy cancer cells

Quantum physics helps destroy cancer cells

Researchers have found a way to enhance radiation therapy using novel iodine nanoparticles.

Microneedles for painless drug delivery

Microneedles for painless drug delivery

Researchers suggest using microneedles for immunotherapy due to the high abundance of immune cells under the skin. The aim is to vaccinate or treat different diseases with minimal invasiveness.

Radiation therapy: 3D printed shields for protection

Radiation therapy: 3D printed shields for protection

To reduce tissue injury side effects from radiation therapy, researchers have developed 3D-printed gastrointestinal radioprotective devices that can be generated from patient CT scans.

Popular articles

Subscribe to Newsletter